Court ruling preserves status quo in several states as fight continues elsewhere over abortion pill

BY: KELCIE MOSELEY-MORRIS
APRIL 19, 2023

As the nation grapples with continuing changes in court rulings affecting the U.S. Food and Drug Administration’s approval of a drug used in abortion care, Washington state’s competing lawsuit and other offensive and defensive moves related to abortion are working exactly as officials and advocates say they intended.

Washington Attorney General Bob Ferguson’s office filed a lawsuit against the FDA in late February, about a month after the federal agency announced it would keep mifepristone, a drug used in tandem with another to end a pregnancy of up to 10 weeks’ gestation, under restrictions associated with its Risk Evaluation and Mitigation Strategies program — also known as REMS.

Continued: https://oregoncapitalchronicle.com/2023/04/19/in-washington-fda-lawsuit-is-part-of-larger-strategy-to-preserve-abortion-access/